Target
Apelin
Ligand
BDBM610970
Substrate
n/a
Meas. Tech.
Measurement of Apelin Receptor Agonist Activity
EC50
71.0±n/a nM
Citation
 Ikeda, TKobayashi, YMiyoshi, NSuzuki, ONagayama, TTsuji, TSmith, LHPinkerton, AB Azole derivatives as apelin receptor agonist US Patent  US10626096 Publication Date 4/21/2020 
Target
Name:
Apelin
Synonyms:
APEL | APEL_HUMAN | APJ endogenous ligand | APLN | Apelin-13 | Apelin-28 | Apelin-31 | Apelin-36
Type:
PROTEIN
Mol. Mass.:
8579.06
Organism:
Homo sapiens (Human)
Description:
ChEMBL_108275
Residue:
77
Sequence:
MNLRLCVQALLLLWLSLTAVCGGSLMPLPDGNGLEDGNVRHLVQPRGSRNGPGPWQGGRRKFRRQRPRLSHKGPMPF
  
Inhibitor
Name:
BDBM610970
Synonyms:
Methyl 4-({[4-(2,6-dimethoxyphenyl)-5-(5-methylfuran-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)benzoate | US10626096, Example 81
Type:
Small organic molecule
Emp. Form.:
C24H23N3O5S
Mol. Mass.:
465.522
SMILES:
COC(=O)c1ccc(CSc2nnc(-c3ccc(C)o3)n2-c2c(OC)cccc2OC)cc1 |(-7.89,-4.84,;-6.8,-3.75,;-5.31,-4.15,;-4.91,-5.64,;-4.22,-3.06,;-4.62,-1.57,;-3.53,-.48,;-2.04,-.88,;-.96,.21,;.53,-.19,;1.62,.9,;1.15,2.36,;2.39,3.27,;3.64,2.36,;5.1,2.84,;6.35,1.93,;7.59,2.84,;7.12,4.3,;7.89,5.64,;5.58,4.3,;3.16,.9,;3.93,-.44,;5.47,-.44,;6.24,.9,;7.78,.9,;6.24,-1.77,;5.47,-3.1,;3.93,-3.1,;3.16,-1.77,;1.62,-1.77,;.85,-3.1,;-1.65,-2.37,;-2.73,-3.46,)|
Structure:
Search PDB for entries with ligand similarity: